|
STT3A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.709900E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.847900E-02 |
| Normal-vs-Stage2 |
1.851230E-01 |
| Normal-vs-Stage3 |
6.426000E-01 |
| Normal-vs-Stage4 |
1.091820E-01 |
| Stage1-vs-Stage2 |
7.534600E-01 |
| Stage1-vs-Stage3 |
3.018200E-01 |
| Stage1-vs-Stage4 |
6.679800E-01 |
| Stage2-vs-Stage3 |
3.619400E-01 |
| Stage2-vs-Stage4 |
9.671000E-01 |
| Stage3-vs-Stage4 |
2.736000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.655800E-02 |
| Normal-vs-AfricanAmerican |
3.352800E-01 |
| Normal-vs-Asian |
9.831200E-01 |
| Caucasian-vs-AfricanAmerican |
7.076900E-03 |
| Caucasian-vs-Asian |
5.991000E-01 |
| AfricanAmerican-vs-Asian |
6.493200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.496600E-01 |
| Normal-vs-Female |
2.942800E-03 |
| Male-vs-Female |
4.301800E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.645000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.128580E-01 |
| Normal-vs-Age(61-80Yrs) |
8.831500E-02 |
| Normal-vs-Age(81-100Yrs) |
7.490200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.513200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.939200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.991600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.243400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.189800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.454600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.964960E-01 |
| Normal-vs-Grade 2 |
9.337700E-02 |
| Normal-vs-Grade 3 |
3.087800E-01 |
| Normal-vs-Grade 4 |
9.778400E-02 |
| Grade 1-vs-Grade 2 |
7.183800E-01 |
| Grade 1-vs-Grade 3 |
3.830800E-01 |
| Grade 1-vs-Grade 4 |
9.783400E-01 |
| Grade 2-vs-Grade 3 |
4.887200E-01 |
| Grade 2-vs-Grade 4 |
5.306200E-01 |
| Grade 3-vs-Grade 4 |
3.083400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.024100E-03 |
| Normal-vs-ccB subtype |
2.209400E-01 |
| ccA subtype-vs-ccB subtype |
1.361180E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.197810E-01 |
| Normal-vs-N1 |
2.472600E-01 |
| N0-vs-N1 |
4.355600E-01 |
|
|
